Bile duct ligation of C57BL/6 mice as a model of hepatic encephalopathy by 援щ낯�� et al.
INTRODUCTION
Hepatic encephalopathy (HE) is a neuropsychiatric syn-
drome of both acute liver failure and chronic liver disease 
with symptoms ranging from subtle fluctuating cognitive 
impairment to coma [1]. It is characterized by personality or 
mood changes, abnormal movements, intellectual impair-
ment, and a depressed level of consciousness [1]. Overt HE 
occurs in 30–40% of patients with cirrhosis, whereas minimal 
HE affects up to 80% of patients with cirrhosis [1,2]. Although 
the incidence of HE is high, there is still a paucity in the un-
derstanding of precise pathogenesis of HE, which calls for 
basic research into the pathogenic mechanism of HE. 
For HE research, a wide range of animals have been used, 
including large animals (dogs, goats, pigs, and rabbits) and 
rodent (rats and mice) [3]. Hepatotoxin models have been 
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Background: Bile duct ligation (BDL) has been used for experimental research on he-
patic encephalopathy (HE) caused by chronic liver disease. However, little research has 
been done on a BDL model in C57BL/6 mouse. Therefore, we evaluated the suitability 
of a BDL model in C57BL/6 mouse for the study of HE and determined which behavioral 
tests are appropriate for the identification of HE in this model. 
Methods: Twelve to fourteen-week-old male C57BL/6 mice were randomly assigned to 
either sham group or BDL group. Histological changes in liver were confirmed by hema-
toxylin/eosin and Masson’s trichrome staining. Liver function alterations were detected 
by alanine aminotransferase (ALT) and ammonia levels. To identify behavioral changes, 
open field, elevated plus maze, novel object recognition, and passive avoidance tests 
were performed.
Results: Inflammatory liver injury and fibrosis were observed 14 days after BDL. ALT 
and ammonia levels were significantly higher in BDL group than in sham group. There 
were no differences in general locomotor activity or anxiety between the groups. No dif-
ference was observed between these two groups in the novel object recognition test, but 
BDL group showed significant learning/memory impairment in the passive avoidance 
test compared to sham group. 
Conclusions: Fourteen days of BDL in 12–14-week-old male C57BL/6 mice is a clini-
cally relevant model for HE, as these mice have liver fibrosis with impaired liver function, 
hyperammonemia, and learning/memory impairment. Passive avoidance can be used 
as the major behavioral test in this model of HE.
Keywords: Bile duct ligation; C57BL/6 mouse; Hepatic encephalopathy; Liver dysfunc-
tion; Passive avoidance test.
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widely used to study HE caused by acute liver failure [3–5]. 
Meanwhile, for the research of HE in chronic liver disease, 
bile duct ligation (BDL) has been used [3,6–11]. BDL in ro-
dents provides a model of secondary biliary fibrosis, which 
is characterized by proliferation of bile ductules, cholestasis, 
portal inflammation, and fibrosis [12,13]. Rats are particularly 
adapted to BDL model because they do not have a gall blad-
der; however, BDL is also used in mice although marked dila-
tion of the gall bladder occurs after BDL [12,14]. 
BDL can be performed by double ligation of the common 
bile duct with or without transection at the midpoint between 
the two ligatures [6–11,13,14]. However, in the case of dis-
section of the bile duct between the ligatures, there is the risk 
of bile leaks if one knot is not secure, which results in severe 
peritonitis and mortality [14]. In C57BL/6 mice, double liga-
tion of the common bile duct without transection success-
fully induces inflammatory liver injury and fibrosis with a low 
mortality rate; liver enzymes such as alanine aminotransfer-
ase (ALT) and aspartate transaminase (AST) peak 10–14 days 
after BDL and periportal fibrosis and perisinusoidal fibrosis 
appear 14 days after BDL [14]. 
Recently, mice are rapidly overtaking rats as the major 
model of choice in biological research; mice accounted for 
about 20% of test animals in the 1970s and 1980s, and then 
grew to around 50% in recent years [15]. This shift may be re-
lated to the availability of techniques for genetic modification 
of mice [15]. Among mice, C57BL/6 mice are the most com-
monly used mouse in biomedical research [15]. A wide array 
of genetically engineered mutant mice on the C57BL/6 back-
ground have provided extensive insights into specific genes 
and pathways involved in different liver diseases; therefore, 
C57BL/6 mice remain the most widely used strain in liver re-
search [15]. However, whether BDL in C57BL/6 mice is useful 
for HE research has not been established. Our aims in this 
study were to evaluate the suitability of a BDL model using 
C57BL/6 mouse for the study of HE and to determine which 
behavioral test is appropriate for the identification of HE in 
this model. 
MATERIALS AND METHODS
Animals 
All procedures were approved by the Institutional Ani-
mal Care and Use Committee (IACUC) of Yonsei University 
Health System (no. 2018-0068). Twelve to fourteen-week-
old male C57BL/6 mice (Orient Bio, Korea) were used for 
this study. Mice were randomly assigned to sham group (n 
= 12) or BLD group (n = 14). For the 10% possibility of mor-
tality, two more mice were assigned to BDL group. Animals 
were housed under a 12-h light/dark cycle in a temperature-
controlled room with ad libitum access to food and water. 
Surgery for bile duct ligation
All surgery for BDL was performed as described in a previ-
ous study with slight modifications [14]. Sham-operated mice 
were laparotomized without BDL.
1) Anesthesia was induced by inhalation of 4 vol% isoflu-
rane, and maintained with 1.5–2.0 vol% isoflurane in 100% 
oxygen at a flow rate of 1 L/min. 
2) The mouse was placed on a 37°C heated hot plate. The 
abdominal fur of the mouse was removed with an electric fur 
shaver and the eyes were protected by using an eye ointment.
3) The abdominal skin was sterilized with betadine fol-
lowed by 70% ethanol (2–3 times) using cotton swabs.
4) The abdomen was opened by a midline laparotomy ap-
proximately 2 cm in length with a surgical scissor, and the 
connective tissue on top of the peritoneum was dissected us-
ing a pair of scissors as a spreader.
5) The peritoneum was cut along the linea alba to open the 
peritoneal cavity.
6) The cavity was enlarged by inserting a holding suture in 
the sternum, raising the filament of the suture, and fixing it 
on top of the circuit. The peritoneal cavity was enlarged with 
a retractor.
7) The liver was lifted with a moistened (0.9% NaCl solu-
tion) cotton swab so that the ventral side of it stuck to the dia-
phragm and the hilum was clearly visible. The bile duct was 
exposed by caudal movement of the gut.
8) The bile duct was separated from the portal vein and he-
patic artery using micro-serrations forceps (Fig. 1A).
9) A 5–0 silk suture was placed around the bile duct and 
secured with two surgical knots (Fig. 1B). A second cranial li-
gation was added in the same manner but did not dissect the 
bile duct in-between (Fig. 1C). 
10) The ends of the sutures were cut, the sternum was low-
ered, and the retractor was removed.
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11) A 0.9% NaCl solution (0.3–0.5 ml) was applied to the 
peritoneal cavity and the abdominal organs were replaced in 
their physiological positions.
12) The peritoneum and skin were closed with simple 
continuous suture with 5–0 silk, and the operation area was 
sterilized with betadine followed by 70% ethanol (2–3 times) 
using cotton swabs.
13) Intraperitoneal injection of tramadol 0.25 mg/kg was 
performed immediately after surgery. 
Behavioral tests 
All behavioral tests were performed as described in a previ-
ous study with the modifications described below [16]. Symp-
toms of minimal HE include anxiety and impaired memory 
[1,2]. Therefore, open filed test and elevated plus maze test 
were performed to test anxiety, and novel object recognition 
test and passive avoidance test were performed to test mem-
ory. For environmental acclimation, mice were placed into 
a behavior room for 1 h prior to the test. After each trial, the 
apparatus was cleaned with distilled water and then cleaned 
with 70% ethanol and the inter-trial interval was 3 min. Be-
havioral data were automatically analyzed using SMART 
Video Tracking system, which tracks nose, tail, and center of 
the mouse’s body (Panlab Harvard Apparatus, Spain) with 
SMART v2.5.21 software. 
Open field test (13 days after surgery)
After acclimation of the behavior room in the home cage, 
the mouse was gently placed in the center of an open field 
chamber (40 × 40 × 40 cm, JEUNGDO Bio & Plant Co., Ltd., 
Korea) and allowed to move freely for 10 min. The total dis-
tance moved and time spent in the center were recorded and 
analyzed to evaluate general locomotor activity and level of 
anxiety, respectively. 
Elevated plus maze (14 days after surgery)
The maze consisted of two open arms (31 × 6 × 1 cm) and 
two enclosed arms (31 × 6 × 15 cm) with a central open square 
area (5 × 5 × 1 cm), and was elevated by 50 cm (JEUNGDO 
Bio & Plant Co., Ltd.). Mice were individually placed in the 
center facing an open arm and allowed to explore for 5 min. 
Duration of open arm and closed arm entries were recorded. 
Entry was defined as movement of all paws into an arm. The 
percentage of time spent in open arms was measured.
Novel object recognition test (14 days after surgery)
To evaluate recognition memory, the novel object recogni-
tion test was performed in the same chamber of open filed 
test. After 24 h of open filed test, the individual mouse, which 
was habituated to the chamber during open field test, was 
presented with two equal sample objects for familiarization 
and allowed to explore freely for 10 min. After 1 h, one of the 
familiar objects was replaced with a novel object and free ex-
ploration was allowed for 10 min [17]. Recognition memory 
was expressed as the percentage of novel object exploration 
time, which was calculated as (novel object exploration time/
[familiar object exploration time + novel object exploration 
time]) × 100%.
Passive avoidance test (13 and 14 days after surgery)
To evaluate learning/memory as a result of a fear response, 
the passive avoidance test was performed in a 41 × 21 × 30 cm 
plastic chamber consisting of light and dark compartments 
separated by a guillotine door (JEUNGDO Bio & Plant Co., 
Ltd.). The stainless steel grid on the floor of the dark compart-
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Fig. 1. Surgical procedures used for 
bile duct ligation. (A) Separation of the 
bile duct from the portal vein and he-
patic artery. (B) Ligation of the bile duct 
with a 5–0 silk suture. (C) Double liga-
tion of the bile duct without dissection 
between the two ligatures.
ment was capable of administering an electric shock. In the 
training trial (13 days after surgery), each mouse was placed 
in the light compartment and allowed to explore the cham-
ber for 10 s. The door between the two compartments was 
opened 10 s after the mouse was placed on the light compart-
ment and the mouse was allowed to explore and move freely 
into dark compartment. When the mouse entered the dark 
compartment completely, the door was closed and an elec-
tric foot shock (0.5 mA) was applied for 3 s through the steel 
grid on the floor. Twenty-four hours after the training trial (14 
days after surgery), retention trial was performed in the same 
chamber. Identical to the training trial, the mouse was placed 
in the light compartment and then 10 s later, the door was 
opened. The time to enter the dark compartment (transfer la-
tency) was recorded. If the mouse did not enter the dark side 
within 300 s, transfer latency was recorded as 300 s.
Laboratory tests (14 days after surgery)
After behavioral tests, whole blood obtained by cardiac 
puncture and ammonia levels were measured using the 
PocketChem BA PA-4140 (Arkay Inc., Japan) according to 
the manufacturer’s instructions. Analysis of ALT level was 
performed in serum by the Korea Animal Medical Science In-
stitute (KAMSI, Korea) using Hitachi 7180 chemistry analyzer 
(Hitachi High-Technologies Co., Japan). 
Liver histology (14 days after surgery)
Livers were fixed in 4% paraformaldehyde overnight at 4°C, 
embedded in paraffin, and then sectioned to obtain 4-μm 
slices. Hematoxylin and eosin (H&E) and Masson’s trichrome 
staining were performed and stained slides were examined 
using an Olympus BX53 microscope (Olympus, Japan).
Statistical analysis
Data are expressed as mean ± standard deviation or me-
dian (1Q, 3Q) of independent experiments. Normality of dis-
tribution was assessed with D’Agostino-Pearson test. Inde-
pendent t test was used for parametric data (ALT, ammonia, 
total distance moved and time spent in the center [open field 
test], time spent in open arms [elevated plus maze test], and 
percentage of novel object exploration time [novel object rec-
ognition test]), and Mann–Whitney U test was used for non-
parametric data (transfer latency [passive avoidance test]). 
Body weight was analyzed by two-way ANOVA with repeated 
measures in one factor. P < 0.05 was considered statistically 
significant, and all analyses were performed with GraphPad 
Prism Software v7.0 (GraphPad Software, USA).
RESULTS
Histological changes of the liver in the BDL model
To assess histological changes and liver fibrosis, H&E and 
Masson’s trichrome staining were performed 14 days after 
surgery (Fig. 2). In H&E staining, mononuclear cell infiltration 
around the portal vein and massive cytoplasmic degenera-
tion with vacuolated cytoplasm was observed in BDL group. 
Moreover, pyknotic nuclei and hepatocyte necrosis were 
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Fig. 2. Liver tissue with (A) hematoxylin & eosin and (B) Masson’s tri-
chrome stain after 14 days of surgery. The scale bar represents 100 
μm. BDL: bile duct ligation. 
evident in widened areas, especially surrounding the portal 
vein in BDL group (Fig. 2A). In Masson’s trichrome staining, 
marked fibrotic areas (stained blue) around the portal vein 
were revealed in BDL group (Fig. 2B).
Alteration of physiological and biochemical 
parameters in the BDL model
Although body weights were similar between the groups 
before surgery (28.9 ± 1.4 vs. 29.9 ± 1.2 g in sham group and 
BDL group, respectively, P = 0.416), the body weight was sig-
nificantly less in BDL group 14 days after surgery compared 
to the sham group (23.1 ± 1.9 vs. 29.3 ± 1.6 g, respectively, P < 
0.001; Fig. 3A). The level of ALT was more than 25-fold higher 
in BDL group than in sham group (1,013 ± 599 vs. 37 ± 14 U/
L, respectively, P = 0.007; Fig. 3B). In addition, BDL group 
showed a significant increase in blood ammonia levels com-
pared to sham group (297 ± 82 vs. 101 ± 48 μg/dl, respectively, 
P < 0.001; Fig. 3C). 
No alteration of general activity and anxiety in 
BDL model
General locomotor activity (total distance moved) mea-
sured by open field test were not different between the groups 
(2,732 ± 525 vs. 2,343 ± 389 cm in sham group and BDL group, 
respectively, P = 0.114; Fig. 4A). The level of anxiety assessed 
by open field test (time in center) and elevated plus maze 
(time in open arms) were similar between the groups. In open 
field test, 10.9% of time was spent in the center in sham group 
and 8.5% of time in BDL group (P = 0.503; Fig. 4A). In elevated 
plus maze test, 19.9% of time was spent in open arms in sham 
group and 20.1% of time in BDL group (P = 0.977; Fig. 4B). 
Impairment of learning/memory in the BDL 
model
Learning/memory was assessed by novel object recogni-
tion test and passive avoidance test. In the novel object recog-
nition test, the time spent exploring novel objects was similar 
for the two groups (59.9 ± 14.3 vs. 58.5 ± 17.8% in sham group 
and BDL group, respectively, P = 0.571; Fig. 4C). However, in 
the passive avoidance test, transfer latency to enter the dark 
compartment was shorter in BDL group than in sham group 
(48.5 [20.8, 259] vs. 300 [241.5, 300] s, respectively, median 
[1Q, 3Q], P = 0.018), which indicates learning/memory im-
pairment in BDL mice (Fig. 4D). 
DISCUSSION
This study demonstrated that liver fibrosis was induced 
and learning/memory impairment appeared 14 days after 
BDL in C57BL/6 mice. Therefore, this 14 day-BDL model 
in C57BL/6 mouse can be used to study HE and the passive 
avoidance test can be used to identify HE in this model. 
HE is subdivided into type A, which is caused by acute liver 
BDL as a model of hepatic encephalopathy
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Fig. 3. (A) Changes in body weight after 14 days of surgery (n = 8 per group). Level of (B) serum ALT (n = 5 per group) and (C) blood ammonia (n = 7 
per group) after 14 days of surgery. Values are presented as mean ± SD. ALT: alanine aminotransferase, BDL: bile duct ligation. *P < 0.01, †P < 0.001 
vs. sham group. 
failure, type B, which is predominantly due to portosystemic 
bypass or shunting without associated intrinsic liver disease, 
and type C, which is caused by cirrhosis [1]. To create type A 
HE rodent models, various types of hepatotoxic substances 
has been used: thioacetamide, acetaminophen, and carbon 
tetrachloride in rats [3,18–20], and azoxymethane in mice 
[3–5]. Among 6,307 patients who visited the liver clinic of a 
single community hospital in Korea, 3,957 (62.7%) patients 
were diagnosed with chronic hepatitis, whereas 528 (8.4%) 
were diagnosed with acute hepatitis [21]. Therefore, a type C 
HE model may be more appropriate than a type A HE model 
in Korea in that type A HE has different manifestations from 
type C HE such as a prominent increase in intracranial pres-
sure with cerebral edema [1]. 
Since BDL model has features of chronic liver disease and 
is technically relatively simple and quick to perform [13,14], it 
can be considered good experimental models for type C HE 
[3]. In fact, several studies have used BDL model in mice for 
HE research [6–11]. BDL in mice induces inflammatory liver 
injury and fibrosis through obstructive cholestasis [13,14]. 
After BDL, ductular reaction is induced by the proliferation of 
biliary epithelial cells, while hepatocytes in areas of prolifer-
ated bile ducts undergo necrosis and apoptosis [13,14]. As the 
degree of fibrosis after BDL can be dependent on the genetic 
background, sex, and age of the mice [12,13], confirmation of 
liver fibrosis is crucial in each mouse strain that is planned for 
use. In the present study, double ligation of the common bile 
duct without transection was applied in male C57BL/6 mice, 
and inflammatory liver injury and fibrosis were observed 14 
days after BDL with mortality rate of 7% (1 of 14). Therefore, 
a 14-day BDL model can be applied in male C57BL/6 mouse 
for research on chronic liver disease. 
To evaluate brain function alterations in a disease model, 
determination of appropriate time points for behavioral tests 
Anesth Pain Med  Vol. 15  No. 1
24 www.anesth-pain-med.org
Sham
4,000
3,000
2,000
1,000D
is
ta
n
c
e
m
o
v
e
d
(c
m
)
0
BDL Sham
20
15
10
5T
im
e
in
c
e
n
te
r
(%
)
0
BDL Sham
40
30
20
10
T
im
e
in
o
p
e
n
a
rm
s
(%
)
0
BDL
A BOpen field Open field Elevated plus maze
Sham
100
80
60
40
20
E
x
p
lo
ra
ti
o
n
o
f
n
o
v
e
l
o
b
je
c
t
(%
)
0
BDL
C Novel object recognition
Sham
400
300
200
100T
ra
n
s
fe
r
la
te
n
c
y
(s
e
c
)
0
BDL
D Passive avoidance
*
Fig. 4. (A) Total distance moved (left) and percentage of time spent in the center zone (right) in the open field test (n = 8 per group). (B) Percentage of 
time spent in the open arms in the elevated plus maze test (n = 8 per group). (C) Percentage of novel object exploration time in the novel object rec-
ognition test (n = 8 per group). (D) Transfer latency to enter the dark compartment in the passive avoidance test (n = 8 per group). Transfer latency is 
expressed using a box plot with median (solid line), interquartile range (box), plus maximum and minimum values (whiskers). Other values are pre-
sented as mean ± SD. BDL: bile duct ligation. *P < 0.05 vs. sham group.
is important. In previous studies using BDL model, behav-
ioral tests were performed at a different time point [6–11]. In 
studies using female Sabra mice (8 weeks of age, 25–30 g), 
eight-arm maze test (learning/memory) and open filed test 
(motor function) were performed 3 weeks after BDL [8,9]. 
Meanwhile, in studies using male NMRI mice (25–35 g), 
passive avoidance test (learning/memory) and novel object 
recognition test (learning/memory) were performed 24 days 
after BDL and 4 weeks after BDL, respectively [10,11]. There-
fore, we had to determine the time point for behavioral tests, 
as no previous study had evaluated learning/memory func-
tion in C57BL/6 mice after BDL. In previous studies using 
male C57BL/6 mice (6–8 weeks of age), recruitment of acti-
vated monocytes into the brain were observed 10 days after 
BDL [6,7], which implies that inflammatory responses were 
already triggered in the brain 10 days after BDL. In the pres-
ent study, impairment of learning/memory was identified by 
a passive avoidance test 14 days after BDL when liver fibrosis 
and elevation of ALT were also observed. A previous study 
reported that ALT and AST peaked after 10–14 days, total bili-
rubin reached a plateau after 7 days, and periportal fibrosis 
and perisinusoidal fibrosis manifested after 14 days of BDL 
[14], thus 14 days of BDL may be appropriate to investigate 
secondary organ dysfunction in liver disease. 
Mice aged 12–14 weeks were used in the present study, in 
contrast to previous studies that used 6–8-week-old C57BL/6 
mice [6,7]. Many investigators choose 8–12-week-old mice 
usually because of cost; however, many developmental 
processes occur during this timeframe that can have a large 
impact on experimental variables [22]. Three- to six-month-
old C57BL/6 mice (equivalent to 20–30 human years) are 
considered mature adult mice [22]. Therefore, we argue that 
12- to 14-week-old male C57BL/6 mice are good candidates 
for research on HE. 
In the present study, general locomotor activity was as-
sessed by an open field test (total distance moved) and anxi-
ety was assessed by an open field test (time in center) and 
elevated plus maze test (time in open arms) [23,24]. General 
locomotor activity was not impaired and anxiety was not 
increased 14 days after BDL in C57BL/6 mice. To investigate 
hippocampus-dependent learning/memory, we used a novel 
object recognition test and passive avoidance test [23–25]. 
No difference between BDL and sham-operated mice was 
observed in the novel object recognition test; however, BDL 
mice showed significant learning/memory impairment in 
a passive avoidance test compared to sham-operated mice. 
The reason for memory impairment in the passive avoidance 
test but not novel object recognition test may be due to the 
different stress intensities of the two tests. Novel object rec-
ognition test is relatively less stressful, however the passive 
avoidance test is fairly stressful because the mouse receives 
an aversive stimulus (electric foot shock) when entering a 
comfortable environment (dark compartment) [23–25]. In 
fact, the passive avoidance test has been used in various 
models of brain disease to evaluate learning/memory impair-
ment because strong memory retention can be gained after a 
single training trial in most mouse strains [24]. Therefore, the 
passive avoidance test may be the best option to detect mini-
mal HE in C57BL/6 mice. 
Although the correlation between blood ammonia level 
and severity of HE is not always consistent, ammonia is a 
crucial factor in the pathogenesis of HE [26]. This is sup-
ported by the fact that neurological/psychiatric symptoms 
and electroencephalographic abnormalities improve when 
blood ammonia levels are lowered in HE patients [27,28]. 
Moreover, the severity of HE has been found to correlate well 
with blood and brain ammonia levels in animal models of 
HE [29,30], and feeding rodents a high-ammonia diet is one 
of the methods used to induce HE in rodents [3]. Therefore, a 
high level of blood ammonia, along with an abnormal behav-
ioral test, can serve as supportive evidence of HE in mice. In 
our study, blood ammonia levels were approximately double 
in BDL mice than sham-operated mice, which supports our 
argument that a 14-day BDL model in C57BL/6 mouse is a 
clinically relevant model for HE. However, further studies in-
vestigating the effects of hyperammonemia on the alteration 
of signal transduction pathway, gene expression, and astro-
cyte function are needed to confirm the development of HE. 
In conclusion, a 14-day BDL model using 12- to 14-week-
old male C57BL/6 mice is an appropriate HE model of chron-
ic liver disease as evidenced by liver fibrosis with impaired 
liver function, hyperammonemia, and learning/memory 
impairment. Passive avoidance can be considered as the pri-
mary behavioral test of HE in this model. 
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